Industry
Drug Manufacturers - Specialty & Generic
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Loading...
Open
13.20
Mkt cap
7.2B
Volume
9.2M
High
14.75
P/E Ratio
-5.69
52-wk high
18.80
Low
12.87
Div yield
N/A
52-wk low
10.19
Portfolio Pulse from Shanthi Rexaline
February 26, 2024 | 10:33 am
Portfolio Pulse from Benzinga Insights
February 26, 2024 | 9:47 am
Portfolio Pulse from Benzinga Insights
February 23, 2024 | 2:01 pm
Portfolio Pulse from Vandana Singh
February 05, 2024 | 3:49 pm
Portfolio Pulse from Avi Kapoor
February 05, 2024 | 3:32 pm
Portfolio Pulse from Benzinga Newsdesk
February 05, 2024 | 2:15 pm
Portfolio Pulse from Benzinga Newsdesk
February 05, 2024 | 11:40 am
Portfolio Pulse from Benzinga Insights
January 17, 2024 | 5:00 pm
Portfolio Pulse from Benzinga Newsdesk
January 17, 2024 | 3:17 pm
Portfolio Pulse from Avi Kapoor
January 05, 2024 | 6:13 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.